Autopsy report · NCT02431169

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Low accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years 2 months before it stopped.
5 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: Washington University School of Medicine
Sponsor type: University, hospital or other
Conditions: Carcinoma, Non-Small-Cell-Lung; Non-Small Cell Lung Cancer; Nonsmall Cell Lung Cancer
Participants: 5
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.